FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

75115009: Fluoxetine hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
124761011 Fluoxetine hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
815689016 Fluoxetine hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
124761011 Fluoxetine hydrochloride en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
124761011 Fluoxetine hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
815689016 Fluoxetine hydrochloride (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
815689016 Fluoxetine hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
38281000188119 fluoxétine chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
812621000172110 chlorhydrate de fluoxétine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
38281000188119 fluoxétine chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
812621000172110 chlorhydrate de fluoxétine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fluoxetine hydrochloride Is a Product containing fluoxetine (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Fluoxetine hydrochloride Is a Fluoxetine false Inferred relationship Existential restriction modifier (core metadata concept)
Fluoxetine hydrochloride Has disposition Serotonin reuptake inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Fluoxetine hydrochloride Is modification of (attribute) Fluoxetine true Inferred relationship Existential restriction modifier (core metadata concept)
Fluoxetine hydrochloride Is a Selective serotonin re-uptake inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Fluoxetine hydrochloride Is a allergène médicamenteux false Inferred relationship Existential restriction modifier (core metadata concept)
Fluoxetine hydrochloride Is a Propylamine true Inferred relationship Existential restriction modifier (core metadata concept)
Fluoxetine hydrochloride Is a Antidepressant (substance) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Fluoxetine hydrochloride 20mg/5mL solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 40 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Fluoxetine (as fluoxetine hydrochloride) 4 mg/mL oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Fluoxetine (as fluoxetine hydrochloride) 60 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing fluoxetine and olanzapine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Fluoxetine (as fluoxetine hydrochloride) 4 mg/mL oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 20 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluoxetine hydrochloride 20 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 40 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Fluoxetine (as fluoxetine hydrochloride) 10 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule Has basis of strength substance (attribute) False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule Has basis of strength substance (attribute) False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule Has basis of strength substance (attribute) False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule Has basis of strength substance (attribute) False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule Has basis of strength substance (attribute) False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 20 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Fluoxetine (as fluoxetine hydrochloride) 60 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Fluoxetine (as fluoxetine hydrochloride) 10 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 40 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule Has basis of strength substance (attribute) False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely fluoxetine hydrochloride 20 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluoxetine hydrochloride 20 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule Has basis of strength substance (attribute) False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Fluoxetine (as fluoxetine hydrochloride) 10 mg oral capsule Has precise active ingredient True Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluoxetine hydrochloride 20 milligram/1 each conventional release oral tablet Has precise active ingredient False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 20 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Fluoxetine (as fluoxetine hydrochloride) 60 mg oral capsule Has precise active ingredient True Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 40 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule Has precise active ingredient False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule Has precise active ingredient False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule Has precise active ingredient False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule Has precise active ingredient False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule Has precise active ingredient False Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Fluoxetine (as fluoxetine hydrochloride) 4 mg/mL oral solution Has precise active ingredient True Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Fluoxetine (as fluoxetine hydrochloride) 90 mg gastro-resistant oral capsule Has precise active ingredient True Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Fluoxetine (as fluoxetine hydrochloride) 20 mg oral tablet Has precise active ingredient True Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Fluoxetine (as fluoxetine hydrochloride) 25 mg and olanzapine 6 mg oral capsule Has precise active ingredient True Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Fluoxetine (as fluoxetine hydrochloride) 50 mg and olanzapine 6 mg oral capsule Has precise active ingredient True Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Fluoxetine hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start